MAPT and Alzheimer disease: Plasma Aβ (the Aβ42/40 ratio) and phosphorylated tau (p‐tau) herald the presence of AD in reference to cerebrospinal fluid (CSF) and positron emission tomography (PET) signatures.19, 20